Mutagenesis vol. 19 no. 6 © UK Environmental Mutagen Society 2004; all rights reserved.
Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points
1Zhejiang University Medical College, Institute of Occupational and Environmental Health, Hangzhou 310006, Zhejiang and 2Jiaxing University Medical College, Jiaxing, 314001, Zhejiang, People's Republic of China
In this paper the genetic damage for three genetic end-points was studied in cancer patients during radiotherapy using the micronucleus test, comet assay and hprt gene mutation test. The subjects were from: (i) a group of 24 patients suffering from various types of cancers; (ii) a group of 23 controls matched according to age, sex and smoking. Blood samples were collected from the controls and from the cancer patients prior to radiotherapy and after cumulative radiation doses of 10, 30 and 50 Gy. The results of the micronucleus test indicated that the mean micronuclei rate (MNR) and mean micronucleated cells rate (MCR) in the cancer patients prior to radiotherapy were 12.46 and 11.29
, respectively, which were significantly higher than those (6.65 and 5.96) in controls (P < 0.01). However, the results of the comet assay and hprt gene mutation test showed no significant difference between untreated cancer patients and controls (P > 0.05). The mean MNR/MCR at 0, 10, 30 and 50 Gy in cancer patients increased with the cumulative dose, being 12.46, 35.83, 64.63 and 85.00 for MNR and 11.29, 31.25, 53.63 and 67.28 for MCR, respectively. Similar results were obtained in the comet assay and hprt gene mutation test. Meanwhile, it was found that there was inter-individual variability in response to radiotherapy among patients.
3 To whom correspondence should be addressed at: Zhejiang University, Medical College, Institute of Occupational and Environmental Health, Hangzhou 310006, Zhejiang, People's Republic of China. Tel: +86 571 87217188; Fax: +86 571 87217382; Email: he_jiliang{at}hotmail.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Herrera, G. Dominguez, J. M. Garcia, C. Pena, C. Jimenez, J. Silva, V. Garcia, I. Gomez, R. Diaz, P. Martin, et al. Differences in Repair of DNA Cross-links between Lymphocytes and Epithelial Tumor Cells from Colon Cancer Patients Measured In vitro with the Comet Assay Clin. Cancer Res., September 1, 2009; 15(17): 5466 - 5472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. McKenna, S. R. McKeown, and V. J. McKelvey-Martin Potential use of the comet assay in the clinical management of cancer Mutagenesis, May 1, 2008; 23(3): 183 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hoffmann, J. Hogel, and G. Speit The effect of smoking on DNA effects in the comet assay: a meta-analysis Mutagenesis, November 1, 2005; 20(6): 455 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Deng, M. Zhang, J. He, W. Wu, L. Jin, W. Zheng, J. Lou, and B. Wang Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points Mutagenesis, September 1, 2005; 20(5): 351 - 357. [Abstract] [Full Text] [PDF]
|
|